Loading...

Bionano Genomics, Inc.

BNGO•NASDAQ
Healthcare
Medical - Diagnostics & Research
$1.21
$0.00(0.00%)
U.S. Market opens in 23h 2m

Bionano Genomics, Inc. (BNGO) Stock Overview

Explore Bionano Genomics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4M
P/E Ratio-0.25
EPS (TTM)$-4.85
ROE-0.56%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.07
3 Months$5.00
1 Year Target$0.00

BNGO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bionano Genomics, Inc. (BNGO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.25 and a market capitalization of 4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.00%
5-Day Change
-5.47%
1-Month Change
2.54%
3-Month Change
-25.31%
6-Month Change
-37.31%
Year-to-Date (YTD) Change
-20.92%
1-Year Change
-71.53%
3-Year Change
-99.74%
5-Year Change
-99.97%
All-Time (Max) Change
-98.03%

Contact Information

https://www.bionanogenomics.com
858 888 7600
9540 Towne Centre Drive, San Diego, CA, 92121

Company Facts

98 Employees
IPO DateAug 21, 2018
CountryUS
Actively Trading

Frequently Asked Questions